An engaging overview of the latest fintech and digital banking trends —...
Fundamentals for Apollo Hospitals Enterprise Limited
Last Updated:
2026-02-01 19:31
Overall Fundamental outlook
Business Operations:
Sector: Healthcare Industry: Medical Care Facilities
Apollo Hospitals Enterprise Limited, together with its subsidiaries, engages in the provision of healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, orthopedics, oncology, neurosciences, emergency, robotic surgery, and transplants; and cardiology, neurology, gastroenterology, dermatology, ophthalmology, pediatric, endocrinology, gynecology, urology, nephrology, pulmonology, rheumatology, neurosurgery, radiology, plastic-surgery, neonatology, vascular-surgery, psychiatry, dentistry, ear, nose, and throat care, as well as genomic medicines. The company also provides other services, such as project consultancy, health insurance, medical colleges, medvarsity for e-learning, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, dialysis centers, cradle and fertility centers, diabetes management centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. Further, the company engages in the business of bio-banking of tissues. It serves through national retail healthcare centers and genomics institutes, as well as Apollo 24/7, a digital health mobile platform; and www.apollopharmacy.in, an online pharmacy. The company was incorporated in 1979 and is based in Chennai, India.
Revenue projections:
Revenue projections for APOLLOHOSP Investors may react cautiously to news that Apollo Hospitals Enterprise Limited's revenues are forecasted to be lower than last year's. Such declines are likely to have a negative effect on the company's bottom line, which can lead to concerns about profitability and hinder investor confidence in the company's future performance.
Financial Ratios:
currentRatio
1.641000
forwardPE
40.984688
debtToEquity
83.606000
earningsGrowth
0.260000
revenueGrowth
0.128000
grossMargins
0.339100
operatingMargins
0.114750
trailingEps
116.170000
forwardEps
167.806580
Apollo Hospitals Enterprise Limited's current ratio being 1.641 shows it has more than enough assets to cover its short-term debts. The company's liquidity position is strong, with ample cash reserves available to meet its immediate financial obligations without strain. APOLLOHOSP's high debt-to-equity ratio suggests a heavily leveraged capital structure. The company relies on debt to fund operations, which could heighten financial risks, particularly if economic conditions deteriorate or profitability declines. APOLLOHOSP's positive earnings and revenue growth suggest the company is on a path to business expansion. This upward trend signals strong financial health, indicating that APOLLOHOSP is well-positioned for sustained growth in both profits and revenue. APOLLOHOSP's forward EPS being higher than its trailing EPS indicates that the company is expected to achieve greater profitability this financial year. This suggests improving earnings and a stronger financial position compared to the previous year's performance.
Price projections:
Price projections for APOLLOHOSP The steady upward revision of APOLLOHOSP's price projections indicates growing confidence in the company's future. Analysts are increasingly optimistic about APOLLOHOSP's potential to deliver strong results and increased market value.
Insider Transactions:
Insider Transactions for APOLLOHOSP
Apollo Hospitals Enterprise Limited saw 3 buy transactions, with market price of 6553.183268229167.During the period under consideration, there were no buy transactions.The trend of more sells than buys around APOLLOHOSP's current price levels suggests possible weakness. If this pattern continues, it could lead to additional price declines, as selling pressure might increase, signaling investor concerns.
Recommendation changes over time:
Recommendations trend for APOLLOHOSP
With analysts showing a buy bias for APOLLOHOSP, investors may be more inclined to see the stock as an attractive investment. The favorable outlook could spur increased interest, positioning APOLLOHOSP as a safe and profitable place for investors to allocate their funds and seek growth.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An investor-focused analysis of how 2025 tariffs are reaching consumers in 2026,...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.